Sequencing Consumables Market Size Will be USD 50.75 Bn By 2033

The global sequencing consumables market size is expected to increase USD 50.75 billion by 2033 from USD 6.94 billion in 2023 with a CAGR of 18.14% between 2024 and 2033.

Key Takeaways

  • Asia Pacific contributed more than 49.28% of the market share in 2023.
  • North America is estimated to expand the fastest CAGR between 2024 and 2033.
  • By form, the bricks & shaped segment has held the largest market share of 55% in 2023.
  • By form, the monolithic & unshaped segment is anticipated to grow at a remarkable CAGR of 5.8% between 2024 and 2033.
  • By product, the clay segment generated over 66% of the market share in 2023.
  • By product, the non-clay segment is expected to expand at the fastest CAGR over the projected period.
  • By alkalinity, the basic segment generated over 59% of the market share in 2023.
  • By alkalinity, the acidic & neutral segment is expected to expand at the fastest CAGR over the projected period.
  • By end-use industry, the iron & steel segment generated over 36% of market share in 2023.
  • By end-use industry, the cement segment is expected to expand at the fastest CAGR over the projected period.
Refractories Market Size 2024 To 2033

The Sequencing Consumables Market is a dynamic sector within the biotechnology and genomics industry, primarily focusing on the production and supply of consumable products essential for various sequencing technologies. These consumables play a pivotal role in processes such as DNA sequencing, RNA sequencing, and other genomic applications. As the field of genomics continues to advance, the demand for high-quality and efficient sequencing consumables is witnessing substantial growth. Key components in this market include reagents, kits, and other consumables that are integral to the sequencing workflow.

Growth Factors:

Several factors contribute to the growth of the Sequencing Consumables Market. The increasing adoption of next-generation sequencing (NGS) technologies in research and clinical applications is a significant driver. Additionally, the rise in genomic research activities, coupled with the declining costs of sequencing, has expanded the accessibility of these technologies, boosting the demand for sequencing consumables. Technological advancements in sequencing platforms and the growing focus on personalized medicine further fuel market growth. Moreover, collaborations between biotechnology companies and academic research institutions contribute to the development of innovative consumable products, fostering market expansion.

Get a Sample: 


The Sequencing Consumables Market is characterized by notable trends that shape its landscape. One prominent trend is the shift towards automation in sequencing workflows, leading to the development of consumables compatible with automated platforms. Another trend is the increasing emphasis on single-cell sequencing, driving the demand for specialized consumables catering to this emerging application. Furthermore, the industry is witnessing a trend towards the development of eco-friendly and sustainable consumables, aligning with global initiatives for environmentally responsible practices.

Region Snapshot

The market for sequencing consumables exhibits a global presence, with key regional variations. North America holds a substantial share, attributed to the presence of major biotechnology companies, academic research institutions, and a high level of funding for genomics research. Europe follows closely, with a well-established biotechnology sector. Asia-Pacific is experiencing rapid growth, driven by increased investment in life sciences research and a rising focus on precision medicine in countries like China and India. The market dynamics in each region are influenced by factors such as regulatory policies, research funding, and technological adoption rates.

Sequencing Consumables Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 18.14%
Global Market Size in 2023 USD 6.94 Billion
Global Market Size by 2033 USD 50.75 Billion
U.S. Market Size in 2023 USD 2.53 Billion
U.S.Market Size by 2033 USD 13.39 Billion
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Product, By Platform, and By Application
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

By Product:

The Sequencing Consumables Market is diversified based on product categories, encompassing a range of essential components required for various sequencing processes. Key product segments include sample preparation kits, sequencing reagents, library preparation kits, and ancillary materials. Sample preparation kits play a crucial role in extracting and purifying nucleic acids, ensuring high-quality genetic material for downstream sequencing applications. Sequencing reagents include enzymes, buffers, and chemicals necessary for the sequencing reactions, while library preparation kits assist in constructing DNA libraries for next-generation sequencing (NGS) platforms. The availability and innovation of these diverse product categories cater to the specific needs of researchers across different sequencing applications.

By Platform:

The market is further segmented based on sequencing platforms, reflecting the compatibility and specialization of consumables for distinct technologies. Major platforms include Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, and others. Each platform has its unique sequencing methodology and requirements, necessitating platform-specific consumables for optimal performance. For instance, Illumina sequencing platforms may require specific reagents and adapters tailored to their technology, while Oxford Nanopore Technologies relies on consumables designed for nanopore sequencing. This segmentation allows manufacturers to tailor their products to the specifications of different sequencing platforms, ensuring efficiency and compatibility.

By Application:

The Sequencing Consumables Market caters to a wide array of applications within genomics research. Key application segments include research and academic institutions, pharmaceutical and biotechnology companies, clinical laboratories, and others. Academic and research institutions utilize consumables for diverse genomics studies, ranging from basic research to advanced applications like whole-genome sequencing. Pharmaceutical and biotechnology companies rely on sequencing consumables for drug discovery, biomarker identification, and genomic profiling. Clinical laboratories utilize these consumables in diagnostic applications, such as identifying genetic mutations associated with diseases. The market segmentation by application recognizes the varied needs of different end-users and ensures the availability of consumables tailored to specific research and diagnostic requirements.

Read Also: Plastic Processing Machinery Market Size to Attain USD 35.58 Bn By 2033

Recent developments in the Sequencing Consumables Market

  • In October 2022, Illumina (US) collaborated with GenoScreen (France) to extend genomic testing accessibility for multidrug-resistant tuberculosis, particularly in countries heavily affected by tuberculosis. This partnership aims to enhance diagnostic capabilities and contribute to the global effort to combat tuberculosis.
  • In October 2022, Illumina (US) entered into a strategic research collaboration with AstraZeneca (UK). The partnership focuses on improving pharmaceutical pipelines by leveraging genomic insights to identify genetic variants associated with human diseases. This collaboration underscores the increasing importance of genomics in drug development and precision medicine.
  • In September 2022, Thermo Fisher Scientific (US) achieved FDA approval for the Oncomine Dx Target Test. This marked a milestone as the first Next-Generation Sequencing (NGS)-based companion diagnostic, designed to aid in therapy selection for patients with RET mutations/fusions in thyroid cancers. The FDA approval highlights the growing role of genomics in guiding personalized treatment decisions for cancer patients.

Competitive Landscape:

The Sequencing Consumables Market features a competitive landscape with several key players vying for market share. Companies engage in strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their product portfolios and expand their global presence. Established players often focus on continuous innovation, introducing new and advanced consumables to stay ahead in the market. The competitive environment is also shaped by collaborations between consumable manufacturers and sequencing platform providers, aiming to offer integrated solutions. Key players leverage their expertise in reagent and kit development to address the evolving needs of researchers and clinicians in the genomics field.

Sequencing Consumables Market Companies

  • Illumina, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • Qiagen N.V. (Netherlands)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Agilent Technologies, Inc. (US)
  • Pacific Biosciences of California, Inc. (US)
  • PerkinElmer, Inc. (US)
  • Oxford Nanopore Technologies Ltd. (UK)
  • Bio-Rad Laboratories, Inc. (US)
  • BGI Genomics Co., Ltd. (China)
  • GenScript Biotech Corporation (China)
  • Eurofins Scientific (Luxembourg)
  • Macrogen Inc. (South Korea)
  • New England Biolabs, Inc. (US)
  • Swift Biosciences, Inc. (US)

Segments Covered in the Report

By Product

  • Kits
  • Reagents
  • Accessories

By Platform

  • 1st Generation sequencing consumables
  • 2nd Generation sequencing consumables
  • 3rd Generation sequencing consumables

By Application

  • Cancer Diagnostics
  • Infectious Disease Diagnostics
  • Reproductive Health Diagnostics
  • Pharmacogenomics
  • Agrigenomics
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333







Fabio Thomas 

Fabio Thomas 

Fabio is a Senior Editor at Reports Gazette who focused on healthcare it news. Also, he is a writer and public health researcher.  He joins Reports Gazette from Modern Healthcare, where he worked as a web producer since 2020. Before joining the Modern Healthcare team, Fabio received a master’s degree in journalism from Northwestern University. He is the author of a 2016-17 book, he is also the recipient of numerous awards.

View all posts by Fabio Thomas  →

Leave a Reply

Your email address will not be published. Required fields are marked *